Drug

Ethanolamine oleate

As of the edition of 20 October 2026, Ethanolamine oleate is a small molecule: marketed, first approved in 1988 (US); no US protection is listed.

Sources: FDA Orange Book and Purple Book, other approval registers, ClinicalTrials.gov, ChEMBL.

The drug

Status
Marketed; latest approval 2017
Kind
Small molecule
Brand name
Ethamolin
First approved
22 December 1988 (US)
Approvals on record
2 in 2 regions
Holder of the most recent approval
Fuji Chemical Industries Co., Ltd.; 2 holders in all

US protection

No US protection is listed.

The FDA registers list no drug-substance patent or exclusivity that counts for this drug.

This is the US only.

Who has held its approvals

CompanyRoleYears
QOL MedicalAcquired holder2005 to now